BRIEF-Insys Therapeutics down 19.3 percent premarket after subpoena

NEW YORK Fri Dec 13, 2013 8:33am EST

NEW YORK Dec 13 (Reuters) - Insys Therapeutics Inc : * Down 19.3 percent premarket after subpoena from Office of Inspector General of the Department of Health and Human Services

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.